How to Delete MyFibroScan. save (37.67 MB)
Published by ECHOSENS on 2024-04-19We have made it super easy to delete MyFibroScan account and/or app.
Table of Contents:
Guide to Delete MyFibroScan š
Things to note before removing MyFibroScan:
- The developer of MyFibroScan is ECHOSENS and all inquiries must go to them.
- The GDPR gives EU and UK residents a "right to erasure" meaning that you can request app developers like ECHOSENS to delete all your data it holds. ECHOSENS must comply within 1 month.
- The CCPA lets American residents request that ECHOSENS deletes your data or risk incurring a fine (upto $7,500 dollars).
āŖļø Steps to delete MyFibroScan account:
1: Visit the MyFibroScan website directly Here →
2: Contact MyFibroScan Support/ Customer Service:
- 100% Contact Match
- Developer: Liver-IT
- E-Mail: support-it@echosens.com
- Website: Visit MyFibroScan Website
Deleting from Smartphone š±
Delete on iPhone:
- On your homescreen, Tap and hold MyFibroScan until it starts shaking.
- Once it starts to shake, you'll see an X Mark at the top of the app icon.
- Click on that X to delete the MyFibroScan app.
Delete on Android:
- Open your GooglePlay app and goto the menu.
- Click "My Apps and Games" » then "Installed".
- Choose MyFibroScan, » then click "Uninstall".
Have a Problem with MyFibroScan? Report Issue
š About MyFibroScan
1. - Agileā¢3+ is an aid to identify NAFLD patients with advanced fibrosis by combining VCTEā¢ and routine clinical parameters to reduce the need for liver biopsy.
2. FibroscanĀ® provides unique and patented biomarkers, LSM by VCTEā¢ (Liver Stiffness Measurement) and CAPā¢ (Controlled Attenuation Parameter) that benefit from a worldwide clinical evidence with over 2500 peer-reviewed publications and 60+ international guidelines.
3. Good to excellent performance in cohorts from different clinical settings (NAFLD tertiary care unit, screening, bariatric surgery) and geographical origins (USA, Europe, Asia).
4. High clinical performances are demonstrated in large external validation cohorts from different geographical origins.
5. High clinical performances are demonstrated in large external validation cohorts from different geographical origin.
6. - Agileā¢4 is an aid to early identify NAFLD patients with cirrhosis by combining VCTEā¢ and routine clinical parameters.
7. While the scores are about specific medical and healthcare issues, they are not a substitute for/or replacement of personalized medical advice and are not intended to be used as the sole basis for making individualized medical or health-related decisions.
8. The Interpretation Guide utilizes data from clinical studies to assist providers in interpreting FibroscanĀ® examination results.
9. Scores enhance FibroscanĀ® liver disease assessment with biological markers.
10. - Fastā¢ is an aid to identify at risk NASH patients defined as NASH + NASā„4 + Fā„2.
11. FibroScanĀ® is the non-invasive solution for comprehensive management of liver health.
12. Scores are presented as educational services intended for licensed healthcare professionals.
13. It can help the physicians to manage the disease to prevent liver-related complications such as hepatocellular carcinoma.
14. Several publications advocate the use of Fastā¢.
